Stock VTRVENTAS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ventas, Inc. Stock

Equities

VTR

US92276F1003

Specialized REITs

Market Closed - Nyse
Other stock markets
 04:00:01 2025-04-17 pm EDT 		5-day change 1st Jan Change
67.93 USD +0.44% Intraday chart for Ventas, Inc. +3.55% +15.35%
Apr. 11 Jefferies Adjusts Price Target on Ventas to $84 From $93 MT
Apr. 08 Ventas Insider Sold Shares Worth $3,165,935, According to a Recent SEC Filing MT

Valuation: Ventas, Inc.

Capitalization 29.69B 26.11B 24.33B 22.4B 41.17B 2,536B 46.54B 286B 112B 1,130B 111B 109B 4,221B P/E ratio 2025 *
127x
P/E ratio 2026 * 93.4x
Enterprise value 42.36B 37.25B 34.7B 31.96B 58.73B 3,618B 66.4B 408B 160B 1,612B 159B 156B 6,022B EV / Sales 2025 *
7.83x
EV / Sales 2026 * 7.33x
Free-Float
95.41%
Yield 2025 *
2.82%
Yield 2026 * 3.02%
More valuation ratios * Estimated data

Chart: Ventas, Inc.

Dynamic Chart

Latest news: Ventas, Inc.

Jefferies Adjusts Price Target on Ventas to $84 From $93 Apr. 11 MT
Ventas Insider Sold Shares Worth $3,165,935, According to a Recent SEC Filing Apr. 08 MT
Deutsche Bank Adjusts Ventas Price Target to $80 From $70, Maintains Buy Rating Apr. 02 MT
Raymond James Adjusts Price Target on Ventas to $74 From $68, Maintains Outperform Rating Mar. 18 MT
Mizuho Adjusts Price Target on Ventas to $75 From $68 Mar. 17 MT
Citigroup Adjusts Price Target on Ventas to $80 From $72, Keeps Buy Rating Mar. 13 MT
The return of recession fears Mar. 10Our Logo
Morgan Stanley Adjusts Ventas Price Target to $70 From $65, Maintains Equalweight Rating Mar. 10 MT
Wells Fargo Adjusts Price Target on Ventas to $77 From $72, Keeps Overweight Rating Mar. 10 MT
Analyst recommendations: American Airlines, Costco, Docusign, Hewlett Packard, Okta… Mar. 10Our Logo
Argus Upgrades Ventas to Buy From Hold, Price Target is $75 Mar. 07 MT
BofA Securities Upgrades Ventas to Buy From Hold, Price Target is $75 Mar. 07 MT
JPMorgan Adjusts Price Target on Ventas to $73 From $71, Keeps Neutral Rating Mar. 07 MT
More news

Last Transcript: Ventas, Inc.

Logo Ventas, Inc.
Ventas, Inc. Presents at Citi?s 30th Annual Global Property CEO Conference 2025, Mar-04-2025 01:30 PM
Mar. 04
More transcripts

Analysts' recommendations: Ventas, Inc.

Jefferies Adjusts Price Target on Ventas to $84 From $93 Apr. 11 MT
Deutsche Bank Adjusts Ventas Price Target to $80 From $70, Maintains Buy Rating Apr. 02 MT
Raymond James Adjusts Price Target on Ventas to $74 From $68, Maintains Outperform Rating Mar. 18 MT
Mizuho Adjusts Price Target on Ventas to $75 From $68 Mar. 17 MT
Citigroup Adjusts Price Target on Ventas to $80 From $72, Keeps Buy Rating Mar. 13 MT
More recommendations

Press Releases: Ventas, Inc.

Ventas Announces First Quarter 2025 Earnings Release Date and Conference Call Apr. 07 AQ
Ventas Announces First Quarter 2025 Earnings Release Date and Conference Call Apr. 04 BU
Ventas : Citi 2025 Global Property CEO Conference Mar. 04 PU
Ventas to Participate in Investor Meetings at Citi 2025 Global Property CEO Conference Mar. 03 AQ
Ventas to Participate in Investor Meetings at Citi 2025 Global Property CEO Conference Feb. 28 BU
More press releases

News in other languages: Ventas, Inc.

Cartera Estadounidense: Últimas compras Dec. 11
RECOMENDACIONES DE LOS ANALISTAS UK/EE.UU.: Epam Systems, Five9, T-Mobile, Lyft, Under Armour... 24-08-09
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK: Nvidia, The Home Depot, Palantir, Target, Lowe's, Block, Rollins... 24-05-07
Las medidas de estímulo en Alemania impulsan las ventas al por menor en agosto 20-09-30
Trump veut porter l'estocade à la "tech" chinoise 20-08-07
More news

Quotes and Performance

1 day+0.44%
1 week+3.55%
Current month-1.21%
1 month-1.19%
3 months+15.33%
6 months+5.56%
Current year+15.35%
More quotes

Course Extremes

1 week
66.32
Extreme 66.32
68.62
1 month
60.15
Extreme 60.15
71.36
Current year
56.68
Extreme 56.68
71.36
1 year
42.66
Extreme 42.66
71.36
3 years
35.33
Extreme 35.33
71.36
5 years
25.38
Extreme 25.38
71.36
10 years
13.34
Extreme 13.345
76.8
More quotes

Managers and Directors: Ventas, Inc.

Manager TitleAgeSince
Debra Cafaro CEO
 Chief Executive Officer 67 1998-12-31
Bob Probst DFI
 Director of Finance/CFO 57 2014-10-26
James Hutchens CIO
 Chief Investment Officer 50 2023-01-22
Director TitleAgeSince
Debra Cafaro CHM
 Chairman 67 1998-12-31
Matthew Lustig BRD
 Director/Board Member 64 2011-05-11
Melody Barnes BRD
 Director/Board Member 61 2014-09-16
More insiders

ETFs: Ventas, Inc.

Name Weight AuM 1st Jan change
CSIF (IE) FTSE EPRA NAREIT DEVELOPED GREEN BLUE UCITS ETF B - USD ETF CSIF (IE) FTSE EPRA Nareit Developed Green Blue UCITS ETF B - USD
4.03% 0 M€ -.--% -
SYGNIA ITRIX GLOBAL PROPERTY ETF ETF Sygnia Itrix Global Property ETF
2.26% 5,898 M€ -0.18% -
VANECK GLOBAL REAL ESTATE UCITS ETF - EUR ETF VanEck Global Real Estate UCITS ETF - EUR
1.91% 301 M€ -5.19% -
NOMURA NEXT FUNDS INTERNATIONAL REIT S&P DEVELOPED REIT INDEX (EX JAPAN UNHEDGED) ETF - JPY ETF Nomura NEXT FUNDS International REIT S&P Developed REIT Index (ex Japan Unhedged) ETF - JPY
1.43% 160 M€ -12.96% -
More ETFs: Ventas, Inc.

Healthcare REITs

Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Change 5d. change 1-year change 3-years change Capi.($)
VENTAS, INC. Stock Ventas, Inc.
+0.44%+3.55%+60.86%+11.97% 29.69B
WELLTOWER INC. Stock Welltower Inc.
+1.13%+3.85%+64.18%+53.36% 95.49B
HEALTHPEAK PROPERTIES, INC. Stock Healthpeak Properties, Inc.
+0.91%+3.19%+3.76%-46.47% 13.1B
OMEGA HEALTHCARE INVESTORS, INC. Stock Omega Healthcare Investors, Inc.
+0.70%+2.39%+28.74%+40.41% 10.87B
HEALTHCARE REALTY TRUST INCORPORATED Stock Healthcare Realty Trust Incorporated
0.00%+3.56%+14.35%-42.95% 5.61B
CARETRUST REIT, INC. Stock CareTrust REIT, Inc.
+0.45%+3.90%+22.24%+64.10% 5.4B
AMERICAN HEALTHCARE REIT, INC. Stock American Healthcare REIT, Inc.
+0.96%+5.70%+135.28% - 4.82B
SABRA HEALTH CARE REIT, INC. Stock Sabra Health Care REIT, Inc.
-0.17%+5.04%+34.77%+39.97% 4.32B
AEDIFICA SA Stock Aedifica SA
+1.05%+10.92%+17.79%-42.12% 3.65B
NATIONAL HEALTH INVESTORS, INC. Stock National Health Investors, Inc.
+0.61%+5.72%+27.24%+35.76% 3.46B
Average +0.61%+4.35%+40.92%+12.67% 17.64B
Weighted average by Cap. +0.87%+3.08%+53.62%+32.22%
See all sector performances

Financials

2025 *2026 *
Net sales 5.41B 4.76B 4.43B 4.08B 7.5B 462B 8.48B 52.06B 20.37B 206B 20.3B 19.87B 769B 5.82B 5.12B 4.77B 4.39B 8.07B 497B 9.13B 56.02B 21.92B 222B 21.84B 21.39B 828B
Net income 243M 213M 199M 183M 336M 20.72B 380M 2.33B 913M 9.23B 910M 891M 34.48B 348M 306M 285M 262M 482M 29.68B 545M 3.34B 1.31B 13.23B 1.3B 1.28B 49.41B
Net Debt 12.67B 11.14B 10.38B 9.56B 17.56B 1,082B 19.85B 122B 47.69B 482B 47.53B 46.53B 1,801B 12.96B 11.4B 10.62B 9.78B 17.97B 1,107B 20.31B 125B 48.79B 493B 48.62B 47.6B 1,842B
More financial data * Estimated data

Company Profile

Logo Ventas, Inc.
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities. At the end of 2024, the Group's portfolio comprised 1,387 assets, divided between nursing homes for the elderly (835), outpatient care facilities (397) and other (155; nursing homes, long-term acute care facilities, inpatient rehabilitation facilities, etc.). Net sales are distributed geographically as follows: the United States (88.7%), Canada (10.7%) and the United Kingdom (0.6%).
Employees
498
Sector
Specialized REITs
Calendar
Apr. 29 - Q1 2025 Earnings Release
More about the company

Quotes

Date Price Change Volume
25-04-17 67.93 $ +0.44% 2,903,549
25-04-16 67.63 $ -0.22% 2,410,278
25-04-15 67.78 $ +0.56% 2,599,595
25-04-14 67.40 $ +1.95% 2,674,054
25-04-11 66.11 $ +0.78% 3,452,792

Delayed Quote Nyse, April 17, 2025 at 04:00 pm EDT

More quotes

Income Statement and Estimates

More financial data

Ratings

Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
67.93USD
Average target price
75.63USD
Spread / Average Target
+11.34%
Consensus
Profit revisions
Estimate revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. VTR Stock